GForce-PD

Read More

On April 10-11th 2019, over 30 international colleagues joined us in Cambridge, UK for the 6th GForce-PD meeting. This year the meeting coincided with the World Parkinson’s Day – where the Cure Parkinson’s Trust hosted a public engagement meeting surrounding the…

Read More

‘Reprogrammed’ stem cells implanted into patient with Parkinson’s disease Japanese neurosurgeons have implanted ‘reprogrammed’ stem cells into the brain of a patient with Parkinson’s disease for the first time. The condition is only the second for which a therapy has…

Read More

Reprogrammed cells relieve Parkinson’s symptoms in trials Japanese researchers report promising results from an experimental therapy for Parkinson’s disease that involves implanting neurons made from ‘reprogrammed’ stem cells into the brain. A trial conducted in monkeys with a version of…

Read More

Lorenz Studer Awarded the 2017 Ogawa-Yamanaka Stem Cell Prize Lorenz P. Studer, MD, was announced today as the winner of the 2017 Ogawa-Yamanaka Stem Cell Prize by the Gladstone Institutes. Studer is the director of the Center for Stem Cell…

Read More

Trials of embryonic stem cells to launch in China Jason Lee/Reuters In the next few months, surgeons in the Chinese city of Zhengzhou will carefully drill through the skulls of people with Parkinson’s disease and inject 4 million immature neurons…

Read More

Congratulations to GForce-PD member Malin Parmar on being a elected into the 2016 class of NYSCF Robertson Investigators NYSCF Announces the Six Members of the 2016 Class of NYSCF – Robertson Investigators NYSCF announced the 2016 class of NYSCF –…

Read More

Stem cell researcher from Lund University receives the Fernström Prize Is it possible to convert a patient’s own skin cells into functioning nerve cells? Or insert

Read More

Boom in unproven cell therapies intensifies regulatory debate Steve Gschmeissner/SPL Thomas Albini met his first patient blinded by a stem-cell ‘treatment’ last year. The elderly woman, who had macular degeneration, thought she was paying to participate in a clinical trial…

Read More